The NCI Genomic Data Commons as an engine for precision medicine
- PMID: 28600341
- PMCID: PMC5533202
- DOI: 10.1182/blood-2017-03-735654
The NCI Genomic Data Commons as an engine for precision medicine
Abstract
The National Cancer Institute Genomic Data Commons (GDC) is an information system for storing, analyzing, and sharing genomic and clinical data from patients with cancer. The recent high-throughput sequencing of cancer genomes and transcriptomes has produced a big data problem that precludes many cancer biologists and oncologists from gleaning knowledge from these data regarding the nature of malignant processes and the relationship between tumor genomic profiles and treatment response. The GDC aims to democratize access to cancer genomic data and to foster the sharing of these data to promote precision medicine approaches to the diagnosis and treatment of cancer.
Figures
References
-
- Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013;153(1):17-37. - PubMed
-
- Dang L, Su SM. Isocitrate dehydrogenase mutation and (R)-2-hydroxyglutarate: from basic discovery to therapeutics development [published online ahead of print 3 April 2017]. Annu Rev Biochem. doi:10.1146/annurev-biochem-061516-044732. - PubMed
-
- Stein EM, Fathi AT, DiNardo CD, et al. Enasidenib (AG-221), a potent oral inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) enzyme, induces hematologic responses in patients with myelodysplastic syndromes (MDS) [abstract]. Blood. 2016;128(22). Abstract 343.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
